| Operating Income (202 206 210 211) | 
                    | 1. Income from sales of merchandise goods (203 through 205) | 
                    | a) to related legal entities | 
                    | b) on domestic market | 
                    | c) on foreign market | 
                    | 2. Income from sale of products (207 through 209) | 
                    | a) to related legal entities | 
                    | b) on domestic market | 
                    | c) on foreign market  | 
                    | 3. Income from activation or consumption of goods, products and services | 
                    | 4. Other operating income | 
                    | Operating Expenses (213 214 215 219 220 221 222 223 224) | 
                    | 1. Merchandise goods sold at cost | 
                    | 2. Materials expenses  | 
                    | 3. Wages, salaries and other employee benefits expenses (216 through 218) | 
                    | a) Gross wages and gross salaries | 
                    | b) Other employee expenses | 
                    | c) Other individual expenses | 
                    | 4. Services expense | 
                    | 5. Depreciation | 
                    | 6. Provisions expenses | 
                    | 7. Immaterial expense | 
                    | Increase in value of products in stock | 
                    | Decrease in value of products in stock | 
                    | Operating income (201-212) | 
                    | Operating Loss (212-201) | 
                    | Finance Income (228 through 233) | 
                    | 1. Finance income from related legal entities | 
                    | 2. Interest income | 
                    | 3. Foreign exchange gains | 
                    | 4. Incomes from currency clause | 
                    | 5. Income from joint venture investments | 
                    | 6. Other finance income | 
                    | Finance Expenses (235 through 239) | 
                    | 1. Finance expenses from relations with related legal entities  | 
                    | 2. Interests expense | 
                    | 3. Foreign exchange losses | 
                    | 4. Currency clause expenses | 
                    | 5. Other finance expense | 
                    | Finance income (227-234) | 
                    | Finance loss (234-227) | 
                    | Operating income(225-226 240-241) > 0 | 
                    | Operating loss (225-226 240-241) < 0 | 
                    | Other income (245 through 253) | 
                    | 1. Income from sale of fixed assets | 
                    | 2. Income from sale of investment property  | 
                    | 3. Income from sale of biological assets | 
                    | 4. Income from sale of stakes in capital and long-term securities | 
                    | 5. Income from sale of materials | 
                    | 6. Surpluses | 
                    | 7. Collected written-off receivables | 
                    | 8. Incomes from contractually agreed risk protection | 
                    | 9. Written-off liabilities, termination of provisions and other incomes | 
                    | Other expenses (255 through 263) | 
                    | 1. Losses arising from sale and write-off of fixed assets | 
                    | 2. Losses arising from sale and write off of investment property | 
                    | 3. Losses arising from sale and write off of biological assets | 
                    | 4. Losses from sale of stakes in capital and long-term securities | 
                    | 5. Losses from sale of materials | 
                    | 6. Deficits | 
                    | 7. Losses from risk protection | 
                    | 8. Losses from revaluation and write-offs | 
                    | 9. Losses from products in stocks and other losses  | 
                    | Gain from other incomes and expenses (244-254) | 
                    | Loss from other incomes and expenses (254-244) | 
                    | Income from revaluation of value (267 through 275) | 
                    | 1. Income from revaluation of intangible assets | 
                    | 2. Income from revaluation of real-estates, plant and equipment | 
                    | 3. Income from revaluation of investment property which is subject to depreciation | 
                    | 4. Income from revaluation of biological assets which are subject to depreciation | 
                    | 5. Income from revaluation of long-term financial placements and financial assets available for sale | 
                    | 6. Income from revaluation of products in stock | 
                    | 7. Income from revaluation of short-term financial placements | 
                    | 8. Income from revaluation of capital value | 
                    | 9. Income from revaluation of other property value | 
                    | Losses from revaluation of proprerty value (277 through 284) | 
                    | 1. Impairment of intangible assets | 
                    | 2. Impairment of real-estates, plant and equipment | 
                    | 3. Impairment of investment property which is subject to depreciation  | 
                    | 4. Impairment of biological assets which are subject to depreciation | 
                    | 5. Impairment of long-term financial placements and financial assets available for sale  | 
                    | 6. Impairment of products in stock | 
                    | 7. Impairment of short-term financial placements | 
                    | 8. Impairment of other property value | 
                    | Increase of the value of specific fixed assets (286 through 288) | 
                    | Increase of the value of investment properties that are not subject to depreciation | 
                    | Increase of the value of biological assets that are not subject to depreciation | 
                    | Increase of the value of other property values that are not subject to depreciation | 
                    | Decrease of the value of specific fixed assets (290 through 292) | 
                    | Decrease of the value of investment properties that are not subject to depreciation | 
                    | Decrease of the value of biological assets that are not subject to depreciation | 
                    | Decrease of the value of other property values that are not subject to depreciation | 
                    | Revaluation gain (266-276 285-289) > 0 | 
                    | Revaluation loss (266-276 285-289) < 0 | 
                    | Incomes from changes in accounting policies and corrections from previous year | 
                    | Losses from changes in accounting policies and corrections from previous year | 
                    | Income before taxes (242-243 264-265 293-294 295-296) > 0 | 
                    | Loss before taxes (242-243 264-265 293-294 295-296) < 0 | 
                    | Tax expenses of reporting period | 
                    | Deferred tax expenses of reporting period | 
                    | Deferred tax incomes of reporting period | 
                    | Net income (297-298-299-300 301) > 0 | 
                    | Net loss (297-298-299-300 301) < 0 | 
                    | Income from sale and revaluation of assets available for sale and discontinued operations assets | 
                    | Loss from sale and revaluation of assets available for sale and discontinued operations assets | 
                    | Income from discontinued operations (304-305) | 
                    | Loss from discontinued operations (305-304) | 
                    | Tax on discontinued operations | 
                    | Net income from discontinued operations (306-307-308) > 0 | 
                    | Net loss from discontinued operations (306-307-308) < 0 | 
                    | Net income of the period (302-303 309-310) > 0 | 
                    | Net loss of the period (302-303 309-310) < 0 | 
                    | Interim dividends and other net income distributions during reporting period | 
                    | Gains determined directly in capital (equity) (315 through 320) | 
                    | 1. Gains from realization of revaluation reserves for fixed assets | 
                    | 2. Gains from changes in fair value of securities available for sale | 
                    | 3. Gains arising from translation of financial statements in foreign operations | 
                    | 4. Actuarial gains from defined-benefit plans | 
                    | 5. Effective share of gains arising from cash-flow risk protection | 
                    | 6. Other unrealized gains and gains determined directly in capital (equity) | 
                    | Loss determined directly in capital (equity) (322 through 326) | 
                    | 1. Losses from changes in fair value of securities available for sale | 
                    | 2. Losses arising from translation of financial statements in foreign operations | 
                    | 3. Actuarial losses from defined-benefit plans | 
                    | 4. Effective share of losses arising from cash-flow risk protection | 
                    | 5. Other unrealized losses and losses determined directly in capital (equity) | 
                    | Other total income before tax (314-321) | 
                    | Other total loss before tax (321-314) | 
                    | Accrued Deferred tax on other total income | 
                    | Other total net income (327-328-329) > 0 | 
                    | Other total net loss (327-328-329) < 0 | 
                    | Total net income of the period (327-328-329) > 0 | 
                    | Total net loss of the period (311-312 330-331) < 0 | 
                    | Net income/loss of the period which belongs to owners (311 or 312) | 
                    | a) Majority owners | 
                    | b) Minority owners | 
                    | Total Net income/loss of the period which belongs to owners (332 or 333) | 
                    | a) Majority owners | 
                    | b) Minority owners | 
                    | Earnings per share | 
                    | a) Basic | 
                    | b) Diluted | 
                    | - based on the working hour | 
                    | - according to month ending balance |